View Older Stories View More Recent Stories
-
Centene and Quartet Health expand partnership nationwide to help ensure members have access to critical behavioral health care during COVID-19 pandemic and beyond
-
Liquid Wire Closes $10 Million Series A to Bring Stretchable Electronics Technologies to the Medical Wearables Industry
-
AdaptHealth Closes Previously Announced Acquisitions of Solara Medical Supplies and ActivStyle
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Annexon Closes $100 Million Financing to Advance Broad Pipeline of Classical Complement Therapeutics
-
Somatus Raises $64 Million in Series C Financing to Transform Kidney Care
-
Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AAC
-
Nkarta Therapeutics Presents Preclinical Findings Supporting Gene Editing of Natural Killer Cells and the Combination of Engineered NK plus T Cells at the American Association for Cancer Research (AAC
-
InVitae (NVTA) to Combine with ArcherDX
-
Invitae and ArcherDX to create a global leader in comprehensive cancer genetics and precision oncology
-
Dracen announces two DRP-104 presentations at AACR
-
KemPharm Issues Letter to Shareholders
-
Form 4 Generation Bio Co. For: Jun 16 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
-
Fast-Growing Health Care Service to Provide At-Home COVID-19 Testing and Medical Care for D.C. Residents
-
Melinta Therapeutics (MLNT) to Acquire Tetraphase Pharmaceuticals for $39M, plus $16M in CVRs
-
Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals
-
Melinta Therapeutics Enters Into Agreement to Acquire Tetraphase Pharmaceuticals
-
CureDuchenne Ventures Announces The "CureDuchenne Ventures 2020 Pitch Contest," To Award Two $25,000 Prizes For Novel Ideas In Duchenne Muscular Dystrophy Therapy Development
-
Meditrina, Inc. completes $10M equity financing led by Deerfield
-
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
-
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
-
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
-
Lumos Pharma Reports First Quarter 2020 Results and Provides Update on Clinical and Corporate Activities
-
Lumos Pharma to Participate in the Jefferies 2020 Healthcare Conference
-
Lumos Pharma to Participate in the Jefferies 2020 Healthcare Conference
-
Deerfield Commits Up to $130 Million to Commercialize Drug Discovery at University of Michigan
-
Conventus Orthopaedics, Inc. Announces Acquisition of Flower Orthopedics
-
Lumos Pharma to Report First Quarter 2020 Financial Results and Host a Conference Call on May 28, 2020
-
Lumos Pharma to Report First Quarter 2020 Financial Results and Host a Conference Call on May 28, 2020
-
AdaptHealth Expands Into Diabetes Segment With Accretive Acquisition of Leading Distributor Solara Medical Supplies
-
Maryland Department of Health Partners with Ready Responders to Provide COVID-19 Testing and Medical Evaluations for Residents
-
ARTMS Closes a US$19 Million Series A Financing with Deerfield and Global Health Sciences (GHS) Fund
-
Form 13F-HR DEERFIELD MANAGEMENT For: Mar 31
-
Relode and Ready Responders Announce Partnership to Alleviate Strain During Covid-19 Crisis
-
Endologix Reports First Quarter 2020 Financial Results
-
Nuvo Pharmaceuticals® Announces First Quarter 2020 Results
-
Intersect ENT Announces $65 Million Convertible Notes Investment from Deerfield Management
-
ADC Therapeutics Announces a $115 Million Convertible Credit Facility with Deerfield
-
ADC Therapeutics Announces a $115 Million Convertible Credit Facility with Deerfield
-
DFP Healthcare Acquisitions Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing on or about May 1, 2020
-
Nkarta Therapeutics Appoints Two New Independent Directors
-
Lumos Pharma Hires Biotech Veteran Aaron Schuchart as Chief Business Officer
-
Lumos Pharma Hires Biotech Veteran Aaron Schuchart as Chief Business Officer
-
Melinta Therapeutics Successfully Completes Financial Restructuring
-
Deerfield Closes $840 Million Healthcare Venture Fund
-
Endologix (ELGX) is withdrawing previously issued financial guidance for 2020
-
Endologix Announces Preliminary Financial Results for First Quarter 2020
-
Lumos Pharma Promotes John C. McKew, PhD to Chief Operating Officer and Chief Scientific Officer
-
Lumos Pharma Promotes John C. McKew, PhD to Chief Operating Officer and Chief Scientific Officer
-
Lumos Pharma Appoints Joseph S. McCracken, DVM, MS to Board of Directors Rick Hawkins, CEO, appointed Chairman of the Board

